Youhong Dong

919 total citations
30 papers, 208 citations indexed

About

Youhong Dong is a scholar working on Oncology, Molecular Biology and Pathology and Forensic Medicine. According to data from OpenAlex, Youhong Dong has authored 30 papers receiving a total of 208 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Oncology, 9 papers in Molecular Biology and 7 papers in Pathology and Forensic Medicine. Recurrent topics in Youhong Dong's work include Cancer-related molecular mechanisms research (4 papers), Cancer Mechanisms and Therapy (4 papers) and Chromatin Remodeling and Cancer (3 papers). Youhong Dong is often cited by papers focused on Cancer-related molecular mechanisms research (4 papers), Cancer Mechanisms and Therapy (4 papers) and Chromatin Remodeling and Cancer (3 papers). Youhong Dong collaborates with scholars based in China, Egypt and Taiwan. Youhong Dong's co-authors include Anping Wang, Gang Wu, Dongdong Zhang, Pengchao Hu, Ran Chen, Lin Zhang, Xinxin Ma, Mingyi Li, Zhen Zhou and Yancheng Xu and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and PLoS ONE.

In The Last Decade

Youhong Dong

28 papers receiving 204 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Youhong Dong China 10 95 47 42 30 27 30 208
Shiwei Yang China 10 151 1.6× 33 0.7× 29 0.7× 41 1.4× 26 1.0× 51 266
Huimin Zou China 9 71 0.7× 51 1.1× 41 1.0× 30 1.0× 26 1.0× 24 240
Jenny Mao United States 7 121 1.3× 55 1.2× 77 1.8× 17 0.6× 67 2.5× 11 302
Yun‐Ru Liu Taiwan 11 167 1.8× 40 0.9× 67 1.6× 30 1.0× 52 1.9× 23 305
Maocai Luo China 6 149 1.6× 42 0.9× 22 0.5× 41 1.4× 43 1.6× 15 299
Yizhen Liu China 11 132 1.4× 54 1.1× 64 1.5× 35 1.2× 54 2.0× 38 288
Charbel C. Khoury United States 8 106 1.1× 32 0.7× 29 0.7× 17 0.6× 15 0.6× 14 313
Shuai Chen China 11 143 1.5× 79 1.7× 64 1.5× 29 1.0× 75 2.8× 32 292
Xue-Chun Lu China 9 65 0.7× 17 0.4× 45 1.1× 21 0.7× 29 1.1× 35 212

Countries citing papers authored by Youhong Dong

Since Specialization
Citations

This map shows the geographic impact of Youhong Dong's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Youhong Dong with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Youhong Dong more than expected).

Fields of papers citing papers by Youhong Dong

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Youhong Dong. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Youhong Dong. The network helps show where Youhong Dong may publish in the future.

Co-authorship network of co-authors of Youhong Dong

This figure shows the co-authorship network connecting the top 25 collaborators of Youhong Dong. A scholar is included among the top collaborators of Youhong Dong based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Youhong Dong. Youhong Dong is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Zhang, Mingzhu, et al.. (2025). SMARCA4 Deficiency in Lung Cancer: From Signaling Pathway to Potential Therapeutic Targets. Genes Chromosomes and Cancer. 64(1). e70022–e70022.
3.
Li, Zengyan, Zhiming Wu, Youhong Dong, Xiaojun Yuan, & Dongdong Zhang. (2024). Diffuse infantile hepatic hemangioma successfully treated with propranolol orally: a case report and literature review. Frontiers in Oncology. 14. 1336742–1336742. 1 indexed citations
4.
Liu, Shiyue, Hong Li, Youhong Dong, & Dongdong Zhang. (2023). Case Report: Tumor-to-tumor metastasis with prostate cancer metastatic to lung cancer: the first reported case. Frontiers in Oncology. 13. 1238331–1238331. 2 indexed citations
5.
Liu, Shiyue, Hong Li, Youhong Dong, & Dongdong Zhang. (2023). Synchronous multiple primary cancers involving rectal cancer and pelvic classical hodgkin lymphoma: the first case report. Frontiers in Oncology. 13. 1295533–1295533. 2 indexed citations
6.
7.
Li, Zengyan, Zhiming Wu, Youhong Dong, & Dongdong Zhang. (2022). Clinical Management of Embryonal Tumor with Multilayered Rosettes: The CCMC Experience. Children. 9(10). 1560–1560. 2 indexed citations
8.
Dong, Youhong, et al.. (2022). Multidisciplinary management of pediatric malignant rhabdoid tumor based on 5 years of experience at a tertiary care center. Pediatric Surgery International. 39(1). 51–51. 1 indexed citations
9.
Zhang, Dongdong, et al.. (2021). Upfront Treatment of Pediatric High-Risk Neuroblastoma With Chemotherapy, Surgery, and Radiotherapy Combination: The CCCG-NB-2014 Protocol. Frontiers in Oncology. 11. 745794–745794. 6 indexed citations
10.
Zhang, Dongdong, et al.. (2021). Leukapheresis and Hyperleukocytosis, Past and Future. International Journal of General Medicine. Volume 14. 3457–3467. 15 indexed citations
11.
Dong, Youhong, et al.. (2020). LncRNA HMGA1P4 promotes cisplatin-resistance in gastric cancer.. SHILAP Revista de lepidopterología. 24(17). 8830–8836. 13 indexed citations
12.
Chen, Ran, et al.. (2020). Inhibitory effect of endostar combined with radiotherapy on gastric cancer animal models. World Journal of Surgical Oncology. 18(1). 165–165. 7 indexed citations
13.
Wang, Jing, et al.. (2019). Effects of javanica oil emulsion injection combined with radiotherapy versus radiotherapy alone on the efficacy and safety in patients with esophageal cancer: a pooled analysis of 1269 cases.. PubMed. 22(4). 985–995. 9 indexed citations
14.
Chen, Ran, et al.. (2019). Clinical efficacy of apatinib in treating metastatic gastric cancer and its effect on IL‑17. Oncology Letters. 17(6). 5447–5452. 9 indexed citations
15.
Wang, Jing, Pengchao Hu, Ying Wang, & Youhong Dong. (2019). Therapeutic effect of gefitinib in advanced non-small cell lung cancer and its effect on the EGFR level in peripheral blood.. PubMed. 22(6). 1404–1409. 2 indexed citations
16.
Zhou, Zhen, et al.. (2019). Formononetin ameliorates high glucose‑induced endothelial dysfunction by inhibiting the JAK/STAT signaling pathway. Molecular Medicine Reports. 20(3). 2893–2901. 21 indexed citations
17.
Liang, Yan, Hesheng Luo, Haidong Zhang, Youhong Dong, & Ying Bao. (2018). Oncogene Delta/Notch-Like EGF-Related Receptor Promotes Cell Proliferation, Invasion, and Migration in Hepatocellular Carcinoma and Predicts a Poor Prognosis. Cancer Biotherapy and Radiopharmaceuticals. 33(9). 380–386. 9 indexed citations
18.
19.
20.
Dong, Youhong & Anping Wang. (2014). Aberrant DNA methylation in hepatocellular carcinoma tumor suppression (Review). Oncology Letters. 8(3). 963–968. 29 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Shiwei Yang Breakdown of academic impact, for papers by Huimin Zou Breakdown of academic impact, for papers by Jenny Mao Breakdown of academic impact, for papers by Yun‐Ru Liu Breakdown of academic impact, for papers by Maocai Luo Breakdown of academic impact, for papers by Yizhen Liu Breakdown of academic impact, for papers by Charbel C. Khoury Breakdown of academic impact, for papers by Shuai Chen Breakdown of academic impact, for papers by Xue-Chun Lu
Rankless by CCL
2026